Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Henderson opened an updated salon in Krasnodar

8/29/24 HNFG

Southern Kuzbass reported for 6 months of 2024 by IFRS

8/29/24 UKUZ

KuibyshevAzot reported for 6 months of 2024 by IFRS

8/29/24 KAZT

Binnopharm Group reported for 6 months of 2024 by IFRS

8/29/24 AFKS

VSMPO-AVISMA reported for 6 months of 2024 by IFRS

8/29/24 VSMO

Aeroflot reported for 6 months of 2024 by IFRS

8/29/24 AFLT

Izhstal reported for 6 months of 2024 by IFRS

8/29/24 IGST

UAC reports for 6 months of 2024 by IFRS

8/29/24 UNAC

Korshunovsky GOK reported for 6 months of 2024 by IFRS

8/29/24 KOGK

Chizhik opened a distribution center in the Moscow region

8/29/24 X5